The development of CAR design for tumor CAR-T cell therapy.

The development of CAR design for tumor CAR-T cell therapy.

Oncotarget. 2018 Mar 02;9(17):13991-14004

Authors: Xu D, Jin G, Chai D, Zhou X, Gu W, Chong Y, Song J, Zheng J

Abstract
In recent years, the chimeric antigen receptor modified T cells (Chimeric antigen receptor T cells, CAR-T) immunotherapy has developed rapidly, which has been considered the most promising therapy. Efforts to enhance the efficacy of CAR-based anti-tumor therapy have been made, such as the improvement of structures of CAR-T cells, including the development of extracellular antigen recognition receptors, intracellular co-stimulatory molecules and the combination application of CARs and synthetic small molecules. In addition, effects on the function of the CAR-T cells that the space distance between the antigen binding domains and tumor targets and the length of the spacer domains have are also being investigated. Given the fast-moving nature of this field, it is necessary to make a summary of the development of CAR-T cells. In this review, we mainly focus on the present design strategies of CAR-T cells with the hope that they can provide insights to increase the anti-tumor efficacy and safety.

PMID: 29568411 [PubMed]

https://ift.tt/2pDutre